A 54-year-old Caucasian male with a history of multiple myeloma post–autologous SCT presents with increasing fatigue and progressive anemia complains of fatigue to his hematologist.
This activity is intended for hematologists, oncologists, and other health care professionals managing patients with multiple myeloma.
Upon completion of this activity, participants should be able to:
- Discuss recent advances that can potentially prolong survival and improve quality of life in relapsed/refractory multiple myeloma patients
- Summarize the potential benefits of newer targeted agents and combinations in relapsed/refractory multiple myeloma patients
- Identify individual patient characteristics and variables that have a bearing on therapy and clinical outcome in relapsed/refractory multiple myeloma patients
- Adopt a patient management approach that is sensitive to prior drug toxicities and thereby improve achievement of treatment goals
AMA PRA Category 1 Credit(s)TM
MedCases, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education.
MedCases designates this educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Thomas G. Martin, MD
Clinical Professor, Department of Medicine (Hematology/Oncology), UCSF
Director, Clinical research, Hematologic Malignancies Program
Associate Director, Myeloma Program
San Francisco, California
Harvey A. Mossman, MD
Division of Internal Medicine,
Division of Geriatric Medicine
North Shore-LIJ Health System
Winthrop University Hospital
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is MedCases policy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a provider has with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The following was reported:
Thomas G. Martin
Speaker’s Bureau – Celgene
Consultant, Speaker’s Bureau – Novartis
Harvey A. Mossman, MD, has nothing to disclose
Unapproved Product Use
In accordance with US Food and Drug Administration (FDA) requirements regarding the disclosure of off-label, investigational, or unapproved recommendations for the use of drugs or devices, you are advised that content in this activity contain references to uses of drugs or devices that are off-label, investigational, or unapproved in the United States. The following off-label references are provided for educational purposes and not to endorse off-label use:
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of MedCases’ name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
All information contained within this activity is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.
The MedCases Web site does not define a standard of care, nor is it intended to dictate an exclusive course of management. Sessions are provided for informational and educational purposes only and are not intended as medical advice. This information should not substitute for a visit or consultation with a health care provider.
This program is sponsored by MedCases, LLC.
This activity is supported by an educational grant from Celgene.
Method of Participation
This Internet-based activity takes approximately 30 minutes to complete. You should review the objectives and case, answer the multiple-choice post-test and complete an evaluation form online. Once completed, you will be able to save your certificate to your own computer and print it on your own printer.
To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all post-test questions, completed the post-test survey, and received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
If you have any questions relating to the accreditation of this activity, please contact email@example.com.
If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.